DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations

N. Ngoi; P. G. Pilie; S. A. Piha-Paul; E. E. Dumbrava; S. Fu; D. S. Hong; D. D. Karp; A. Naing; S. Pant; J. Rodon Ahnert; V. Subbiah; A. M. Tsimberidou; C. Salguero; C. V. Brown; W. E. Hoadley; A. Johnson; Y. Yuan; S. N. Westin; F. Meric-Bernstam; T. A. Yap

doi:10.1016/S0959-8049(22)00828-0

DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations

N. Ngoi, P. G. Pilie, S. A. Piha-Paul, E. E. Dumbrava, S. Fu, D. S. Hong, D. D. Karp, A. Naing, S. Pant, J. Rodon Ahnert, V. Subbiah, A. M. Tsimberidou, C. Salguero, C. V. Brown, W. E. Hoadley, A. Johnson, Y. Yuan, S. N. Westin, F. Meric-Bernstam, T. A. Yap

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	S10
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00828-0
State	Published - Oct 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(22)00828-0

Cite this

Ngoi, N., Pilie, P. G., Piha-Paul, S. A., Dumbrava, E. E., Fu, S., Hong, D. S., Karp, D. D., Naing, A., Pant, S., Rodon Ahnert, J., Subbiah, V., Tsimberidou, A. M., Salguero, C., Brown, C. V., Hoadley, W. E., Johnson, A., Yuan, Y., Westin, S. N., Meric-Bernstam, F., & Yap, T. A. (2022). DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations. European Journal of Cancer, 174, S10. https://doi.org/10.1016/S0959-8049(22)00828-0

DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations. / Ngoi, N.; Pilie, P. G.; Piha-Paul, S. A. et al.
In: European Journal of Cancer, Vol. 174, 10.2022, p. S10.

Research output: Contribution to journal › Article › peer-review

Ngoi, N, Pilie, PG , Piha-Paul, SA , Dumbrava, EE , Fu, S , Hong, DS, Karp, DD, Naing, A , Pant, S , Rodon Ahnert, J, Subbiah, V, Tsimberidou, AM , Salguero, C, Brown, CV, Hoadley, WE, Johnson, A, Yuan, Y , Westin, SN , Meric-Bernstam, F & Yap, TA 2022, 'DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations', European Journal of Cancer, vol. 174, pp. S10. https://doi.org/10.1016/S0959-8049(22)00828-0

@article{6e7df3f274fb425d90c329785fb7c939,

title = "DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations",

author = "N. Ngoi and Pilie, {P. G.} and Piha-Paul, {S. A.} and Dumbrava, {E. E.} and S. Fu and Hong, {D. S.} and Karp, {D. D.} and A. Naing and S. Pant and {Rodon Ahnert}, J. and V. Subbiah and Tsimberidou, {A. M.} and C. Salguero and Brown, {C. V.} and Hoadley, {W. E.} and A. Johnson and Y. Yuan and Westin, {S. N.} and F. Meric-Bernstam and Yap, {T. A.}",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00828-0",

language = "English (US)",

volume = "174",

pages = "S10",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial

T2 - Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations

AU - Ngoi, N.

AU - Pilie, P. G.

AU - Piha-Paul, S. A.

AU - Dumbrava, E. E.

AU - Fu, S.

AU - Hong, D. S.

AU - Karp, D. D.

AU - Naing, A.

AU - Pant, S.

AU - Rodon Ahnert, J.

AU - Subbiah, V.

AU - Tsimberidou, A. M.

AU - Salguero, C.

AU - Brown, C. V.

AU - Hoadley, W. E.

AU - Johnson, A.

AU - Yuan, Y.

AU - Westin, S. N.

AU - Meric-Bernstam, F.

AU - Yap, T. A.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140474355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140474355&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00828-0

DO - 10.1016/S0959-8049(22)00828-0

M3 - Article

AN - SCOPUS:85140474355

SN - 0959-8049

VL - 174

SP - S10

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this